July 6, 2026 – (DURHAM, NC) – MED-EL US today announced the consumer availability of its new rechargeable batteries, Standard Pro and Micro Pro, compatible with both SONNET 2 and SONNET 3 audio processors. Offering an extended battery life, these upgraded rechargeable batteries improve usability and flexibility essential to everyday hearing.
The Standard Pro battery delivers up to 23 hours of hearing on a single charge, while the Micro Pro offers up to 12 hours. Both batteries feature a simplified two-part design, fast charging in up to three hours, and support over 1,100 charging cycles. Charging is possible while attached to the processor or separately, with magnetic alignment and LED indicators on the charger for ease of use.
These runtimes are supported across MED‑EL implants dating back to 1994, allowing many existing users to benefit from the upgrade without needing a new implant. Backward compatibility with SONNET 2 also ensures a seamless transition for current users.
"The peace of mind from having a full day of battery life to support all of SONNET 3’s features have been fantastic,” said MED-EL recipient, Scott Murray. “I now have the freedom to wear either the RONDO 3 or the SONNET 3 without giving any thought to spare batteries.”
The new battery kits include child-safe battery covers for added security and easy USB-C charging with the battery on or off the processor, magnetic alignment, and an LED status light. The packaging has also been intentionally designed to be compact and eco-friendly, reducing plastic waste.
Consumers can purchase the new Standard Pro and Micro Pro batteries through the myMED-EL online shop or MED-EL.
About MED-EL
MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 3,100 employees from around 90 nations and 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 140 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. www.medel.com
